Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 72 announcements

Sun Pharmaceutical Industries Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,902.30
Market cap: ₹4,56,426 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 41.6×Sector 43.8×
Promoter holding: 52.68%-1.80% QoQ
FII holding: 14.36%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

28 Sep 2026 08:20 IST BSE

PartnershipAlfa Alert

Sun Pharmaceutical Industries Partnership

Sun Pharma signed a global licensing and commercialization agreement with LIB Therapeutics for lerodalcibep, excluding US and China, strengthening its innovative medicines portfolio.

From: LIB Therapeutics Inc.

Open announcement → Read the story on ALFA News Read the filing ↗

Sun Pharmaceutical Industries Ltd by type

Annual General Meeting 10
Earnings Call 10
Other Announcement 7
Financial Results 6
Management Change 5
Business Update 4
Credit Rating 4
Board Meeting Date 4
Promoter Reclassification 4
Merger & Restructuring 3
Acquisition 3
Price Movement Clarification 2
Regulatory Approval 2
Debt & Borrowing 2
Legal & Regulatory 2